HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephanie Jost Selected Research

Stephanie Jost Research Topics

Disease

16Infections
01/2018 - 07/2008
3Neoplasms (Cancer)
01/2019 - 01/2017
3Human Influenza (Influenza)
04/2011 - 01/2011
1HIV Infections (HIV Infection)
01/2019
1Chronic Disease (Chronic Diseases)
01/2019
1Lentivirus Infections
01/2018
1Castleman Disease (Castleman's Disease)
01/2018
1Lymphoma (Lymphomas)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
03/2016
1Endotoxemia
01/2016
1Virus Diseases (Viral Diseases)
01/2015
1Dengue (Dengue Fever)
03/2011
1Chronic Hepatitis B
07/2008

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2019 - 01/2011
4AntigensIBA
09/2015 - 01/2011
3VaccinesIBA
01/2019 - 08/2014
3LigandsIBA
10/2014 - 08/2011
2Natural Killer Cell ReceptorsIBA
01/2018 - 08/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2017
2Antiviral Agents (Antivirals)IBA
01/2015 - 07/2008
2HLA-C Antigens (HLA-C)IBA
10/2014 - 08/2011
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1Immunoglobulin A (IgA)IBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1Immunoglobulin M (IgM)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2016
1Glycoproteins (Glycoprotein)IBA
01/2015
1HLA-B57 antigenIBA
01/2015
1KIR2DL1 ReceptorsIBA
10/2014
1Protein Subunits (Protein Subunit)IBA
08/2014
1EpitopesIBA
07/2012
1Natural Cytotoxicity Triggering Receptor 1IBA
04/2011
1Polysaccharides (Glycans)IBA
03/2011
1Interleukin-2 (IL2)IBA
01/2011
1Interleukin-15 (Interleukin 15)IBA
01/2011
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2011
1Interleukin-10 (Interleukin 10)IBA
01/2011
1Staphylococcal Protein A (Protein A)IBA
10/2010
1Metalloproteases (Metalloproteinases)IBA
09/2009
1InterferonsIBA
07/2008

Therapy/Procedure

2Stem Cell Transplantation
01/2018 - 01/2017
2Drug Therapy (Chemotherapy)
01/2018 - 01/2017
1Immunotherapy
01/2019
1Hematopoietic Stem Cell Transplantation
01/2018
1Therapeutics
03/2016
1Highly Active Antiretroviral Therapy (HAART)
07/2013